• Accelero_Autumn_2017_1.jpg
  • Accelero_Autumn_2017_2.jpg
  • Accelero_Autumn_2017_3.jpg
  • Accelero_Autumn_2017_3a.jpg
  • Accelero_Autumn_2017_4.jpg
  • Accelero_Autumn_2017_5.jpg
  • Accelero_Autumn_2017_5a.jpg
  • Accelero_Autumn_2017_7.jpg
  • Accelero_Autumn_2017_8.jpg
  • Accelero_Autumn_2017_9.jpg

Accelero Bioanalytics provides expertise in a continuously increasing number of applications.
Please follow the links below to learn more about our services:

 

Non-Clinical Studies (GLP) 
Assay validation, PK/PD bioanalysis for non-GLP DRF and GLP Toxicology Studies

Clinical Studies (ICH GCP) 
Analytical services according to ICH E6 R1 and the Declaration of Helsinki

Advanced Therapy Medicinal Products (ATMP) 
Assay validation for the biodistribution of cell-based genetically engineered drug products

RNA / DNA Therapeutics and Aptamers 
Micro RNA (miRNA) mimics and antagomirs, siRNA, antisense, aptamers, or immuno modulators

Microbiology 
From cultivation to detection or quantification of BSL-2 microbial organisms

Human PBMC Isolation and Cell Culture 
We culture your cell line, or characterize PBMC sub-populations

Anti-Drug Antibodies (ADA) 
Immunogenicity testing for early IgM and late IgG immune response to your drug product

GMP Cell Bank Characterization 
MCB and WCB insert characterization , impurity tests for drug products

 

 

Last update of this site: 13-OCT-2016 by Christian Lange